Radioprotection by antioxidants.

Area of Science:

• Radiation biology
• Pharmacology
• Toxicology

Background:

• Reactive oxygen species (ROS) play a key role in ionizing radiation injury.
• Antioxidants are investigated for their potential to mitigate radiation-induced damage.
• Animal models have been used for over 50 years to study these effects.

Purpose of the Study:

• To review the radioprotective efficacy and toxicity of various antioxidants in mice.
• To compare synthetic thiols with natural antioxidants.
• To explore the potential of other drug classes with antioxidant properties as radioprotectors.

Main Methods:

• Review of scientific literature on radioprotectors.
• Focus on phosphorothioates (e.g., WR-2721, WR-151327), other thiols, and natural antioxidants.
• Examination of animal model data regarding efficacy and toxicity.

Main Results:

• Synthetic thiols like WR-2721 demonstrate significant radioprotective effects.
• Naturally occurring antioxidants (vitamin E, selenium) are less potent but offer a broader protection window against low-dose, low-dose-rate radiation.
• Other agents (nimodipine, propranolol, methylxanthines) possess antioxidant properties and potential radioprotective utility.

Conclusions:

• Synthetic thiols are effective radioprotectors, but toxicity must be considered.
• Natural antioxidants may be beneficial for specific low-dose radiation scenarios and warrant further study for long-term effects.
• Modulating endogenous antioxidants and utilizing drugs with dual pharmacological and antioxidant activity could enhance radiotherapy outcomes.